Beyond Tariffs: UK-Switzerland Deal Prioritizes Services, IP, and the Speed of Business

In a move signaling a strategic emphasis on the intangible assets of modern economies, UK Prime Minister Keir Starmer has sealed a £5.2bn trade deal with Switzerland, described as his likely last major international agreement. This pact goes beyond traditional goods, explicitly targeting an unlock of “£5.2bn a year in additional UK services exports to Switzerland in the long run,” according to the UK’s Department for Business and Trade.

The agreement introduces concrete measures to reduce friction for British nationals, a key feature being the ability to use e-gates at Swiss airports. This initiative will commence later this year with exit checks at Zurich airport, followed by Basel and Geneva next year, which is recognized as a leading hub for business and winter sports. The deal also notably scraps roaming charges and preserves existing trading terms for a range of goods, including medicines, cars, art, and jewellery.

Switzerland already stands as the UK’s sixth-largest market for services, currently valued at approximately £30bn annually, predominantly in financial and other service sectors. Starmer framed the deal as the “sixth landmark agreement” in his two years in office, emphasizing its role in “making life easier and creating more opportunity for people across the UK.” This sentiment was echoed by Rain Newton-Smith, chief executive of the CBI, who highlighted “real opportunities for growth” in services, dubbing them the UK’s “super power.”

**Mobility as the New Currency of Trade**

A critical component of this “gold standard” deal, as described by City of London Corporation policy chair Chris Hayward, is the facilitation of human capital mobility. The agreement introduces visa-free travel for UK services professionals for up to 90 days a year to Switzerland, streamlining what were previously complicated immigration conditions. Reciprocally, the UK will allow visa-free travel for up to 90 days for Swiss companies bringing personnel to deliver contracts, ensuring symmetry in easing cross-border operations. Hayward noted that reducing friction at the border through e-gates and “allowing business travellers more time to do business” had been a priority, underscoring the shift towards valuing efficiency and access for skilled professionals.

**Intellectual Property: A Sticking Point, Now a Standard**

The deal also explicitly addresses intellectual property, a domain often subject to intense negotiation. Both sides have committed to continuing their existing pharmaceutical patent protections. This commitment is particularly salient given prior reports that the UK, under pressure from the Department of Health and Social Care, had considered reducing patent protection lengths to enable quicker NHS access to cheaper generic drugs. Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry, affirmed that both parties “made explicit their commitment to maintain a strong and proportionate intellectual property regime,” signaling a clear victory for IP rights holders within the trade framework.

**Signals for a Services-Driven Global Economy**

This UK-Switzerland agreement serves as a potent indicator of the evolving priorities in international trade. It moves beyond traditional tariff reductions on goods to embed mechanisms that directly support service exports and the mobility of professionals. The explicit £5.2bn target for additional services exports underscores a strategic recognition that future economic growth for advanced economies like the UK lies in leveraging expertise, innovation, and frictionless cross-border collaboration rather than solely physical products. The emphasis on e-gates and visa-free access speaks to a future where the seamless flow of talent and ideas is as crucial as the flow of goods.

The deal, following Starmer’s previous agreements with the US, India, South Korea, and the Gulf states, further delineates the UK’s post-Brexit trade strategy: a diversified portfolio seeking high-value partnerships, particularly in the services sector. The unwavering stance on pharmaceutical patent protections, despite domestic pressures, highlights the delicate balance between international trade obligations and national policy objectives, and the premium placed on maintaining robust IP frameworks in key trading relationships. This “gold standard” approach could well influence future bilateral service agreements in an increasingly interconnected and specialized global marketplace.